Investegate |BioNTech SE Announcements | BioNTech SE: Voting Results from BioNTech's Annual General Meeting 2022
Investegate announcements from BioNTech SE, Voting Results from BioNTech’s Annual General Meeting 2022
Stay updated with breaking news from Biontech Se. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investegate announcements from BioNTech SE, Voting Results from BioNTech’s Annual General Meeting 2022
Investegate announcements from BioNTech SE, Pfizer-BioNTech COVID-19 Vaccine Demonstrates Strong Immune Response, High Efficacy and Favorable Safety in Children 6 Months to Under 5 Years of Age Following Third Dose
A number of firms have modified their ratings and price targets on shares of BioNTech (NASDAQ: BNTX) recently: 5/11/2022 – BioNTech was given a new $255.00 price target on by analysts at The Goldman Sachs Group, Inc.. 5/10/2022 – BioNTech was given a new $183.00 price target on by analysts at JPMorgan Chase & Co.. […]
Stocks that traded heavily or had substantial price changes Monday: Uber, Elanco fall; TreeHouse Foods, Energizer rise
Investegate announcements from BioNTech SE, Pfizer and BioNTech Announce Data Demonstrating High Immune Response Following a Booster Dose of Their COVID-19 Vaccine in Children 5 Through 11 Years of Age